| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 62 |
| 1 | DEXAMETHASONE | 56 |
| 2 | DEXAMETHASONE 1.5 MG | 56 |
| 3 | METHOTREXATE | 56 |
| 4 | PREDNISOLONE | 54 |
| 5 | PREDNISOLONE ORAL | 54 |
| 6 | PREDNISOLONE ORAL SOLUTION | 54 |
| 7 | PREDNISONE | 41 |
| 8 | METHYLPREDNISOLONE | 37 |
| 9 | ADALIMUMAB | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-AEKN | 1 | 0.1667 |
| 1 | SEGESTERONE ACETATE AND ETHINYL ESTRADIOL | 5 | 0.0131 |
| 2 | GUAIFENESIN AND CODEINE PHOSPHATE | 1 | 0.0075 |
| 3 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 2 | 0.0054 |
| 4 | FERRIC DERISOMALTOSE | 7 | 0.0051 |
| 5 | AVATROMBOPAG MALEATE | 10 | 0.0042 |
| 6 | BIVALIRUDIN | 4 | 0.0040 |
| 7 | ANGIOTENSIN II | 1 | 0.0033 |
| 8 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 9 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 1 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 178 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 56 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 51 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 50 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 50 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 41 |
| 6 | Factor Xa Inhibitor [EPC] | 41 |
| 7 | Asparagine-specific Enzyme [EPC] | 36 |
| 8 | Alkylating Drug [EPC] | 33 |
| 9 | Progestin [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 1 | Asparagine-specific Enzyme [EPC] | 36 | 0.0027 |
| 2 | Antifibrinolytic Agent [EPC] | 21 | 0.0021 |
| 3 | Anti-coagulant [EPC] | 7 | 0.0019 |
| 4 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 5 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Osmotic Diuretic [EPC] | 7 | 0.0013 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 19 | 0.0013 |
| 8 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |
| 9 | Interferon alfa-2b [EPC] | 2 | 0.0011 |